Elevation of asymmetrical dimethylarginine may mediate endothelial dysfunction during experimental hyperhomocyst(e)inaemia in humans

Clinical Science

Volumn 100, Issue 2, 2001, Pages 161-167

  Boger R H ^a   Lentz, S R ^a   Bode Boger S M ^a   Knapp, H R ^a   Haynes, W G ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Atherosclerosis; Coronary disease; Endothelial function; Nitric oxide; Ultrasound

Indexed keywords

GLYCERYL TRINITRATE; HOMOCYSTEINE; METHIONINE; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE SYNTHASE; PLACEBO;

ADULT; ARTICLE; BIOAVAILABILITY; BRACHIAL ARTERY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOREARM BLOOD FLOW; FRUIT JUICE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; HYPERHOMOCYSTEINEMIA; MALE; NORMAL HUMAN; PRIORITY JOURNAL; VASCULAR DISEASE; VASCULAR ENDOTHELIUM; VASODILATATION;

ACUTE DISEASE; ADULT; ARGININE; BRACHIAL ARTERY; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; ENDOTHELIUM, VASCULAR; FEMALE; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; METHIONINE; NITROGLYCERIN; VASODILATION; VASODILATOR AGENTS;

EID: 0035109723     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/cs1000161     Document Type: Article

References (38)

1. Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia
2. Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans
3. Endothelial cell dysfunction in homocystinuria
4. Hyperhomocysteinemia: An independent risk factor for vascular disease
5. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians
6. Homocysteine and vascular dysfunction
7. Adverse effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen
8. Endogenous dimethylarginine as an inhibitor of nitric oxide synthesis
9. Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in monkeys with hyperhomocyst(e)inemia
10. Asymmetric dimethylarginine: A novel risk factor for endothelial dysfunction. Its role in hypercholesterolemia
11. Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease
12. RNA and protein interactions modulated by protein arginine methylation
13. Homocyst(e)ine and arterial occlusive diseases
14. Hyperhomocysteinemia after an oral methionine load acutely impairs endothelial function in healthy adults
15. Acute hyperhomocysteinaemia and endothelial dysfunction
16. Role of oxidant stress in endothelial dysfunction produced by experimental hyperhomocyst(e)inemia in humans
17. Flow-mediated and reflex changes in large peripheral artery tone in humans
18. Technical aspects of evaluating brachial artery vasodilatation using high-frequency ultrasound
19. Determination of glutathione isopropyl ester in rat, dog, and human blood by high-performance liquid chromatography with fluorescence detection
20. Elevated L-arginine/dimethylarginine ratio contributes to enhanced systemic NO production by dietary L-arginine in hypercholesterolemic rabbits
21. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo
22. Attenuation of acetylcholine-induced vasoconstriction by L-arginine is related to the progression of atherosclerosis
23. Functional improvement precedes structural regression of atherosclerosis
24. Effect of short-term regression of atherosclerosis on reactivity of carotid and retinal arteries
25. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction
26. Demonstration of rapid onset vascular endothelial dysfunction after hyperhomocysteinemia
27. Consequences of hyperhomocyst(e)inemia on vascular function in atherosclerotic monkeys
28. LDL cholesterol upregulates synthesis of asymmetrical dimethylarginine in human endothelial cells. Involvement of S-adenosylmethionine-dependent methyltransferases
29. G-dimethylarginine dimethylaminohydrolase from rat kidney
30. G-dimethylarginine by human endothelial cells
31. An endogenous inhibitor of nitric oxide synthase regulates endothelial adhesiveness for monocytes
32. Regulation of nitric oxide synthesis by dimethylarginine dimethylaminohydrolase
33. The oxidant stress of hyperhomocyst(e)inemia
34. Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase
35. Homocysteine and endothelial vascular function
36. Intracellular oxidative stress induced by nitric oxide synthesis inhibition increases endothelial cell adhesion to neutrophils
37. Asymmetric dimethylarginine enhances superoxide production in human endothelial cells
38. Endogenous inhibitors of nitric oxide synthesis and lipid peroxidation in hyperlipidemic rabbits